Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Streptococcus pneumoniae: epidemiology and patterns of resistance.

Jacobs MR.

Am J Med. 2004 Aug 2;117 Suppl 3A:3S-15S. Review.

PMID:
15360092
2.
3.
4.

Therapeutic options for pneumococcal pneumonia in Turkey.

Oncu S, Erdem H, Pahsa A.

Clin Ther. 2005 Jun;27(6):674-83. Review.

PMID:
16117975
5.

Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.

Jones RN, Sader HS, Stilwell MG, Fritsche TR.

Diagn Microbiol Infect Dis. 2007 May;58(1):1-7. Epub 2007 Apr 3.

PMID:
17408904
6.

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffe JF, Rakowsky A, Schuchat A, Whitney CG.

Arch Intern Med. 2000 May 22;160(10):1399-408.

PMID:
10826451
8.

Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains.

Paradisi F, Corti G, Cinelli R.

Clin Microbiol Infect. 2001;7 Suppl 4:34-42. Review.

9.

Drug-resistant Streptococcus pneumoniae: rational antibiotic choices.

Jacobs MR.

Am J Med. 1999 May 3;106(5A):19S-25S; discussion 48S-52S. Review.

PMID:
10348060
10.
11.

Streptococcus pneumoniae: does antimicrobial resistance matter?

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2009 Apr;30(2):210-38. doi: 10.1055/s-0029-1202939. Epub 2009 Mar 18. Review.

PMID:
19296420
12.
14.

Drug treatment of pneumococcal pneumonia in the elderly.

Neralla S, Meyer KC.

Drugs Aging. 2004;21(13):851-64. Review.

PMID:
15493950
15.

Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.

Jenkins SG, Brown SD, Farrell DJ.

Ann Clin Microbiol Antimicrob. 2008 Jan 11;7:1. doi: 10.1186/1476-0711-7-1.

16.

Antimicrobial Resistant Streptococcus pneumoniae: Prevalence, Mechanisms, and Clinical Implications.

Cherazard R, Epstein M, Doan TL, Salim T, Bharti S, Smith MA.

Am J Ther. 2017 May;24(3):e361-e369. doi: 10.1097/MJT.0000000000000551. Review.

PMID:
28430673
17.

Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?

Doern GV, Richter SS, Miller A, Miller N, Rice C, Heilmann K, Beekmann S.

Clin Infect Dis. 2005 Jul 15;41(2):139-48. Epub 2005 Jun 7.

PMID:
15983908
19.

Antimicrobial resistance in Streptococcus pneumoniae, Taiwan.

Hsueh PR, Luh KT.

Emerg Infect Dis. 2002 Dec;8(12):1487-91.

20.

Hidden epidemic of macrolide-resistant pneumococci.

Klugman KP, Lonks JR.

Emerg Infect Dis. 2005 Jun;11(6):802-7. Review.

Supplemental Content

Support Center